UNICHEMLAB Stock Overview
A pharmaceutical company, manufactures and sells pharmaceutical products worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Unichem Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹857.95 |
| 52 Week High | ₹937.95 |
| 52 Week Low | ₹400.55 |
| Beta | 0.13 |
| 11 Month Change | 12.06% |
| 3 Month Change | 46.96% |
| 1 Year Change | 106.39% |
| 33 Year Change | 259.28% |
| 5 Year Change | 422.50% |
| Change since IPO | 1,383.83% |
Recent News & Updates
Revenues Tell The Story For Unichem Laboratories Limited (NSE:UNICHEMLAB) As Its Stock Soars 26%
Nov 02
It's A Story Of Risk Vs Reward With Unichem Laboratories Limited (NSE:UNICHEMLAB)
Sep 13Recent updates
Revenues Tell The Story For Unichem Laboratories Limited (NSE:UNICHEMLAB) As Its Stock Soars 26%
Nov 02It's A Story Of Risk Vs Reward With Unichem Laboratories Limited (NSE:UNICHEMLAB)
Sep 13Optimistic Investors Push Unichem Laboratories Limited (NSE:UNICHEMLAB) Shares Up 26% But Growth Is Lacking
Feb 06Is Unichem Laboratories (NSE:UNICHEMLAB) Using Debt Sensibly?
Feb 01Does Unichem Laboratories (NSE:UNICHEMLAB) Have A Healthy Balance Sheet?
Sep 06Unichem Laboratories (NSE:UNICHEMLAB) Is Due To Pay A Dividend Of ₹4.00
Jul 30There's Reason For Concern Over Unichem Laboratories Limited's (NSE:UNICHEMLAB) Massive 28% Price Jump
Jul 23Unichem Laboratories (NSE:UNICHEMLAB) Will Pay A Dividend Of ₹4.00
Jul 15Unichem Laboratories (NSE:UNICHEMLAB) Will Pay A Dividend Of ₹4.00
Jul 01Unichem Laboratories (NSE:UNICHEMLAB) Is Making Moderate Use Of Debt
Nov 27Investors Shouldn't Be Too Comfortable With Unichem Laboratories' (NSE:UNICHEMLAB) Robust Earnings
Jun 05Should Unichem Laboratories Limited (NSE:UNICHEMLAB) Be Part Of Your Income Portfolio?
Mar 02Unichem Laboratories Limited's (NSE:UNICHEMLAB) Stock's Been Going Strong: Could Weak Financials Mean The Market Will Correct Its Share Price?
Feb 09Should You Take Comfort From Insider Transactions At Unichem Laboratories Limited (NSE:UNICHEMLAB)?
Jan 19Do Institutions Own Unichem Laboratories Limited (NSE:UNICHEMLAB) Shares?
Dec 29Is Unichem Laboratories (NSE:UNICHEMLAB) Weighed On By Its Debt Load?
Dec 10Key Things To Understand About Unichem Laboratories' (NSE:UNICHEMLAB) CEO Pay Cheque
Nov 23
Did Unichem Laboratories' (NSE:UNICHEMLAB) Share Price Deserve to Gain 41%?
Nov 02Should You Buy Unichem Laboratories Limited (NSE:UNICHEMLAB) For Its 1.5% Dividend?
Oct 13How Much Are Unichem Laboratories Limited (NSE:UNICHEMLAB) Insiders Spending On Buying Shares?
Sep 16Is Unichem Laboratories (NSE:UNICHEMLAB) Using Too Much Debt?
Aug 26Is Unichem Laboratories Limited's (NSE:UNICHEMLAB) Shareholder Ownership Skewed Towards Insiders?
Aug 05Would Shareholders Who Purchased Unichem Laboratories'(NSE:UNICHEMLAB) Stock Three Years Be Happy With The Share price Today?
Jul 14Shareholder Returns
| UNICHEMLAB | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -4.0% | 0.5% | 0.5% |
| 1Y | 106.4% | 42.5% | 27.5% |
Return vs Industry: UNICHEMLAB exceeded the Indian Pharmaceuticals industry which returned 42.5% over the past year.
Return vs Market: UNICHEMLAB exceeded the Indian Market which returned 27.5% over the past year.
Price Volatility
| UNICHEMLAB volatility | |
|---|---|
| UNICHEMLAB Average Weekly Movement | 6.7% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: UNICHEMLAB has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: UNICHEMLAB's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1944 | 2,875 | Pabitra Kumar Bhattacharya | www.unichemlabs.com |
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services.
Unichem Laboratories Limited Fundamentals Summary
| UNICHEMLAB fundamental statistics | |
|---|---|
| Market cap | ₹60.27b |
| Earnings (TTM) | -₹55.64m |
| Revenue (TTM) | ₹17.75b |
3.4x
P/S Ratio-1,083x
P/E RatioIs UNICHEMLAB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| UNICHEMLAB income statement (TTM) | |
|---|---|
| Revenue | ₹17.75b |
| Cost of Revenue | ₹7.27b |
| Gross Profit | ₹10.48b |
| Other Expenses | ₹10.54b |
| Earnings | -₹55.64m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.79 |
| Gross Margin | 59.06% |
| Net Profit Margin | -0.31% |
| Debt/Equity Ratio | 11.2% |
How did UNICHEMLAB perform over the long term?
See historical performance and comparison